Blume B, Rabe F, Theuring F
Z Urol Nephrol. 1984 Jan;77(1):7-9.
A report is given on a 73-year-old patient in whom a urothelial carcinoma of the urinary bladder developed 11 years after a cyclophosphamide therapy. Taking the international literature into account, possible developmental mechanisms are discussed. Patients who have undergone cyclophosphamide therapy should be subject to constant urological observation as a high-risk group.
报告了一名73岁患者，其在环磷酰胺治疗11年后发生了膀胱尿路上皮癌。考虑到国际文献，讨论了可能的发病机制。接受过环磷酰胺治疗的患者作为高危人群应接受持续的泌尿外科观察。
